---
title: DEA Stops Cannabis Research; Tribes Transiting Unchecked
description: DEA blocks compliant cannabis research as tribal networks distribute unregulated marijuana, exposing regulatory gaps and hindering patient access.
---

[Blog](https://420intel.com/blog)

# [DEA Stops Cannabis Research; Tribes Transiting Unchecked](https://420intel.com/blog/dea-stops-cannabis-research-tribes-transiting-unchecked)

 Written by [Buzz](https://420intel.com/blog/author/buzz) | Jun 24, 2025 1:00:00 PM

**WASHINGTON, DC / ACCESS Newswire / June 23, 2025 / **The U.S. Drug Enforcement Administration (DEA) continues to obstruct legally compliant cannabis research for debilitating conditions like **Multiple Sclerosis (MS)** and **Huntington's Disease (HD)**-even as marijuana distribution networks tied to **tribal transit operations in North Carolina **move quantities of cannabis across state lines with little to no DEA enforcement.

**MMJ BioPharma Cultivation**, a Rhode Island-based biopharmaceutical company, has 2,375 days working with the **FDA** and the **DEA** to bring to market a pharmaceutical-grade cannabinoid soft gelatin capsule for patients in need. Despite holding **orphan drug designation** from the FDA and full compliance with the Controlled Substances Act, MMJ's bulk manufacturing registration remains unjustifiably denied.

"While MMJ has followed every rule, built an FDA-compliant supply chain, and worked transparently with regulators, the DEA has chosen to prioritize obstruction over innovation," said **Duane Boise**, CEO of MMJ BioPharma. "Meanwhile, tribal-linked transit networks not subject to proper DEA scrutiny are distributing untaxed and unregulated marijuana across the country. Where is the oversight?"

A recent senate video investigation (Watch here) highlights how certain non-tribal operators have exploited tribal land and transportation frameworks to move illicit marijuana across state boundaries, posing regulatory and public safety concerns.

By contrast, MMJ's project has been **frozen within a DEA administrative law court system** now widely viewed as unconstitutional following Supreme Court decisions in *Axon v. FTC* and *Jarkesy v. SEC*. In February 2025, the **Department of Justice itself abandoned its defense** of the DEA's ALJ system, admitting it violates the separation of powers under Article II.

 

About MMJ BioPharma Cultivation

MMJ BioPharma Cultivation is a federally compliant cannabis research and manufacturing company working to bring cannabinoid-based therapies through FDA approval for rare and serious neurological diseases.

 

 

[by WJHL](https://www.wjhl.com/business/press-releases/accesswire/1041662/dea-blocks-mmj-fda-cannabis-research-while-tribal-marijuana-transit-networks-operate-in-n-c-unchecked/)

 

 

 

[View full post](https://420intel.com/blog/dea-stops-cannabis-research-tribes-transiting-unchecked)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Buzz"
  },
  "dateModified" : "2025-06-24T13:00:07.042Z",
  "datePublished" : "2025-06-24T13:00:00Z",
  "headline" : "DEA Stops Cannabis Research; Tribes Transiting Unchecked",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1024,
    "url" : "https://23119865.fs1.hubspotusercontent-na1.net/hubfs/23119865/20250624_0757_image.png",
    "width" : 688
  },
  "mainEntityOfPage" : "https://420intel.com/blog/dea-stops-cannabis-research-tribes-transiting-unchecked",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "420Intel Blog"
  }
}
```